Viral Warts Treatment Market Outlook:
Viral Warts Treatment Market size was valued at USD 1.6 billion in 2025 and is projected to reach USD 3.4 billion by the end of 2035, rising at a CAGR of 8.8% during the forecast period, i.e., 2026-2035. In 2026, the industry size of viral wart treatment at USD 1.7 billion.
The rising awareness about skin-related conditions and the growing burden of human papillomavirus are the key factors fueling the augmentation of the market. Testifying to this, the article published by the World Health Organization in March 2024 reported that HPV is a group of over 200 viruses, with some high-risk types causing genital warts and several cancers. It also stated that in a year, HPV was linked to approximately 620,000 cancer cases in women and 70,000 in men, highlighting the strong necessity of effective treatment.
Furthermore, the landscape is influenced by the existence of payers, which include insurance companies, government healthcare systems, and private health plans, that play an extremely crucial role in determining access and affordability of treatments through their pricing and reimbursement policies. In this regard, NIH in October 2021 evaluated six main treatments for genital warts in Peru, finding that the cost per treatment session ranged from USD 11 for trichloroacetic acid to USD 24.59 for surgical excision, with human resources accounting for 70% to 95% of these costs.
